Evidence map›Paper›PMID 28855274›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Presenilin1/γ-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15.

Qian Huang, Georgios Voloudakis, Yimin Ren, Yonejung Yoon, Emily Zhang, Yuji Kajiwara, Zhiping Shao, Zhao Xuan, Denis Lebedev, Anastasios Georgakopoulos and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Qian HuangDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Georgios VoloudakisDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yimin RenDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yonejung YoonDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Emily ZhangDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yuji KajiwaraDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zhiping ShaoDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zhao XuanDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Denis LebedevDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Anastasios GeorgakopoulosDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Nikolaos K RobakisDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, New York, USA; nikos.robakis@mssm.edu.
Icahn School of Medicine at Mount Sinai · US

Funding

VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI NIKOLAOS K ROBAKIS · 2020 to 2026
$31.0M
Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and ADR01NS047229 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GEORGAKOPOULOS, ANASTASIOS, ROBAKIS, NIKOLAOS K · 2004 to 2025
$8.3M
STRUCTURE &EXPRESSION OF THE B-PROTEIN-PRECURSOR GENER01AG008200 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 1988 to 2017
$5.6M
PS1 regulates processing and signaling of ephrinB/EphBR37AG017926 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 2005 to 2014
$3.3M
Effects of PS1FAD mutations on PS1-NMDAR association, necroptosis and electrophysiology.RF1AG008200 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROBAKIS, NIKOLAOS K · 2018 to 2018
$2.8M
PRESENILIN 1 IS A COMPONENT OF THE ADHERENS JUNCTIONSR01AG017926 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 2000 to 2004
$1.8M
NIA NIH HHS P30 AG066514NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG008200NIA NIH HHS R01 AG017926NIA NIH HHS R37 AG017926NIA NIH HHS RF1 AG008200NINDS NIH HHS R01 NS047229
6 · The paper itself

Abstract

Reduced cerebral glucose utilization is found in aged individuals and often is an early sign of neurodegeneration. Here, we show that under glucose deprivation (GD) conditions, decreased expression of presenilin 1 (PS1) results in decreased neuronal survival, whereas increased PS1 increases neuronal survival. Inhibition of γ-secretase also decreases neuronal survival under GD conditions, which suggests the PS1/γ-secretase system protects neurons from GD-induced death. We also show that neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at ∼15 kDa (PEA15), and its mRNA are regulated by PS1/γ-secretase. Furthermore, down-regulation of PEA15 decreases neuronal survival under reduced glucose conditions, whereas exogenous PEA15 increases neuronal survival even in the absence of PS1, which indicates that PEA15 promotes neuronal survival under GD conditions. The absence or reduction of PS1, as well as γ-secretase inhibitors, increases neuronal miR-212, which targets PEA15 mRNA. PS1/γ-secretase activates the transcription factor, cAMP response element-binding protein, regulating miR-212, which targets PEA15 mRNA. Taken together, our data show that under conditions of reduced glucose, the PS1/γ-secretase system decreases neuronal losses by suppressing miR-212 and increasing its target survival factor, PEA15. These observations have implications for mechanisms of neuronal death under conditions of reduced glucose and may provide targets for intervention in neurodegenerative disorders.-Huang, Q., Voloudakis, G., Ren, Y., Yoon, Y., Zhang, E., Kajiwara, Y., Shao, Z., Xuan, Z., Lebedev, D., Georgakopoulos, A., Robakis, N. K. Presenilin1/γ-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15.

Indexed as

Amyloid Precursor Protein SecretasesAnimalsApoptosis Regulatory ProteinsCell DeathCells, CulturedCell SurvivalCyclic AMP Response Element-Binding ProteinGene Expression RegulationGene Knockout TechniquesGlucoseMiceMicroRNAsModels, NeurologicalNeuronsPhosphoproteinsPresenilin-1Amyloid Precursor Protein SecretasesApoptosis Regulatory ProteinsCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinGlucoseMicroRNAsMIRN212 microRNA, mousePea15 protein, mousePhosphoproteinsPresenilin-1presenilin 1, mouseReceptors, N-Methyl-D-AspartateRNA, MessengerCREBmicroRNANMDAR

Identifiers

PMID28855274
PMCPMC5731132
OpenAlexW2751568380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.